- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02360813
Cognitive Remediation Therapy Within a Secure Forensic Setting
Randomised Controlled Trial to Evaluate the Efficacy of Cognitive Remediation Within a Secure Forensic Setting for Schizophrenia Spectrum Patients
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
This is a single centre randomised clinical trial to evaluate the feasibility, effectiveness and patient satisfaction with cognitive remediation therapy within a secure forensic setting for patients diagnosed with schizophrenia or schizoaffective disorder.
The feasibility of the intervention will be assessed using key indicators such as rate of enrolment, retention of patients in the trial, blinding effectiveness, and completion rate of the primary outcome measure. The effectiveness of the intervention will be assessed using the MATRICS consensus cognitive battery, symptoms (PANSS and CAINS) and real world functioning (SOFAS: Social and occupational functioning assessment scale). The effect of cognitive remediation on violence risk (HCR-20), programme completion and recovery (Dundrum 3 & 4) will also be examined, where programme completion is a measure of attainments from participating in additional psychosocial interventions and recovery is a measure of stability of mental state.
Patient satisfaction with cognitive remediation therapy will be assessed using a consumer constructed interview developed by Rose et al (2008) and administered by a social worker not involved in the delivery of cognitive remediation.
The trial will take place at the Republic of Ireland's Central Mental Hospital (CMH). The CMH is the only secure forensic psychiatric hospital for the Republic of Ireland, a population of 4.6 million. CMH provides specialised care for adults who have a mental disorder and are at risk of harming themselves or others.
After a baseline assessment to ensure eligibility and to obtain consent, an estimated 60 patients will be randomised to receive fourteen weeks of cognitive remediation versus treatment as usual. Patients who receive treatment as usual will be offered cognitive remediation upon completion of the study. Patients allocated to cognitive remediation will receive three individual sessions of cognitive remediation a week and one group session, fifty-six sessions in total The focus of the group session is to normalise cognitive difficulties that patients may be experiencing, to receive support and to help generalise gains. The primary outcome measure the MATRICS composite score and secondary outcome measures to assess real world functioning, symptoms, violence risk, programme completion and recovery will be administered at baseline, the end of treatment and at six month follow up. Secondary measures will also include feasibility outcomes and patient satisfaction with cognitive remediation therapy. All evaluators of the effectiveness measures will be blind to participant treatment condition at the time of assessment.
The cognitive remediation therapy is a principle driven intervention consisting of nine treatment principles: Principle 1 refers to relationship building, Principle 2 refers to collaborative goal setting, Principle 3 involves the session structure, Principle 4 concerns the content of the sessions, Principle 5, concerns the pacing of sessions, Principle 6 involves scaffolding and errorless learning, Principle 7 refers to meta-cognitive strategies, Principle 8 involves generalisation of gains, finally Principle 9 refers to managing ambivalence. The actual therapy will involve the use of a combination on pen, paper and computerised materials to stimulate patient's cognitive capacity and to provide them with the opportunity to apply meta-cognitive strategies.
The investigators hypothesise that it is feasible to carry out a randomised controlled trial within a single centre forensic setting and that patients will report high rates of satisfaction with cognitive remediation. It is also hypothesised that patients receiving cognitive remediation therapy will have an improvement in cognitive performance (the primary outcome measure), real world functioning, symptoms and violence risk over time relative to patients receiving treatment as usual; specifically that there will be a treatment by time interaction. Furthermore it is hypothesised that these differences will be maintained at six month follow up after the end of treatment.
In addition it is hypothesised that patients receiving cognitive remediation will show an improvement over time on the Dundrum programme completion and recovery scales compared to those receiving treatment as usual.
While meta-analytic reviews have demonstrated that cognitive remediation therapy has a beneficial effect on the cognitive deficits experienced by patients with schizophrenia (Wykes et al 2011), to the best of our knowledge there has been no study with forensic mental health patients. The current study will help answer whether it is feasible to deliver cognitive remediation within a forensic mental health setting and whether it is acceptable to patients. The study aims to contribute to the evidence base for psychological interventions within a forensic setting and to answer the question as to whether cognitive remediation has a beneficial effect and if it does whether this effect is maintained over time.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Dublin, Irlandia, D 14
- Central Mental Hospital
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- A Structured Clinical Interview for Diagnostic and Statistical Manual IV (SCID) diagnosis of schizophrenia or schizoaffective disorder.
Exclusion Criteria:
- Acutely psychotic, or judged too dangerous to participate in treatment, or being over 65 years of age.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Cognitive Remediation Therapy
Principle driven cognitive remediation therapy, cognitive rehabilitation, cognitive training, cognitive enhancement.
|
Fifty-six sessions of principle driven cognitive remediation therapy.
Three individual sessions and one group session each week for approximately fourteen weeks.
Inne nazwy:
|
Aktywny komparator: Treatment as Usual
Usual care.
|
Keep getting usual care.
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
The MATRICS Consensus Cognitive Battery (MCCB)
Ramy czasowe: Group by time interaction: changes from baseline, to end of treatment (average 5 months)
|
Consensus neuropsychological assessment battery for cognitive deficits in schizophrenia
|
Group by time interaction: changes from baseline, to end of treatment (average 5 months)
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Social and Occupational Functioning Assessment Scale (SOFAS)
Ramy czasowe: Group by time interaction: changes from baseline, to end of treatment (average 5 months)
|
100 item rating scale for measuring real world functioning independent of symptoms
|
Group by time interaction: changes from baseline, to end of treatment (average 5 months)
|
Positive and Negative Syndrome Scale (negative and disorganized factors)
Ramy czasowe: Group by time interaction: changes from baseline, to end of treatment (average 5 months)
|
Rating scale for assessing psychiatric symptoms associated with schizophrenia
|
Group by time interaction: changes from baseline, to end of treatment (average 5 months)
|
Clinical Assessment Interview for Negative Symptoms (CAINS)
Ramy czasowe: Group by time interaction: changes from baseline, to end of treatment (average 5 months)
|
Rating scale for assessing the negative symptoms of schizophrenia
|
Group by time interaction: changes from baseline, to end of treatment (average 5 months)
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Historical Clinical and Risk Management -20 (HCR-20)
Ramy czasowe: Group by time interaction: changes from baseline, to 12 months
|
Rating scale for assessing violence risk
|
Group by time interaction: changes from baseline, to 12 months
|
Dundrum Toolkit: Programme Completion and Recovery Scales
Ramy czasowe: Group by time interaction: changes from baseline to 12 months
|
Rating scale for assessing progress and recovery within a forensic mental health setting
|
Group by time interaction: changes from baseline to 12 months
|
Patient satisfaction.
Ramy czasowe: Average 5 months.
|
Consumer developed interview exploring patient satisfaction with cognitive remediation.
|
Average 5 months.
|
Feasibility outcome: rate of enrolment.
Ramy czasowe: 12 months.
|
Willingness of forensic mental health patients to participate in study.
|
12 months.
|
Feasibility outcome: rate of retention.
Ramy czasowe: 12 months.
|
Number of patients who complete the intervention.
|
12 months.
|
Feasibility outcome: blinding.
Ramy czasowe: 12 months.
|
Number of patients in which the blind is broken compared to number of patients in the study.
|
12 months.
|
Completion rate of primary outcome measures
Ramy czasowe: 12 months.
|
Number of successfully completed primary outcome measures.
|
12 months.
|
Współpracownicy i badacze
Sponsor
Śledczy
- Dyrektor Studium: Professor Harry G Kennedy, M.D., Central Mental Hospital and Department of Psychiatry, Trinity College Dublin.
- Dyrektor Studium: Professor Gary Donohoe, Ph.D., Department of Psychiatry, Trinity College Dublin.
- Główny śledczy: Dr. Ken W O'Reilly, D.Psych.Sc., Central Mental Hospital and Department of Psychiatry, Trinity College Dublin.
Publikacje i pomocne linki
Publikacje ogólne
- Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-76. doi: 10.1093/schbul/13.2.261.
- Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008 Feb;165(2):203-13. doi: 10.1176/appi.ajp.2007.07010042. Epub 2008 Jan 2.
- Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011 May;168(5):472-85. doi: 10.1176/appi.ajp.2010.10060855. Epub 2011 Mar 15.
- Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry. 2013 Feb;170(2):165-72. doi: 10.1176/appi.ajp.2012.12010109.
- Davoren M, Abidin Z, Naughton L, Gibbons O, Nulty A, Wright B, Kennedy HG. Prospective study of factors influencing conditional discharge from a forensic hospital: the DUNDRUM-3 programme completion and DUNDRUM-4 recovery structured professional judgement instruments and risk. BMC Psychiatry. 2013 Jul 9;13:185. doi: 10.1186/1471-244X-13-185.
- Rybarczyk B. (2011). Social and Occupational Functioning Assessment Scale (SOFAS). Encyclopedia of Clinical Neuropsychology. p 2313
- Webster CD, Douglas KS, Eaves D, Hart SD. HCR-20: assessing risk for violence. Burnaby: Mental Health Law and Policy Institute, Simon Fraser University; 1997.
- Rose D, Wykes T, Farrier D, Doran AM, Sporel T & Bogner D (2008) What Do Clients Think of Cognitive Remediation Therapy?: A Consumer-Led Investigation of Satisfaction and Side Effects, American Journal of Psychiatric Rehabilitation. Rehabilitation, 11:2, 181-204.
- O'Reilly K, Donohoe G, O'Sullivan D, Coyle C, Corvin A, O'Flynn P, O'Donnell M, Galligan T, O'Connell P, Kennedy HG. A randomized controlled trial of cognitive remediation for a national cohort of forensic patients with schizophrenia or schizoaffective disorder. BMC Psychiatry. 2019 Jan 15;19(1):27. doi: 10.1186/s12888-019-2018-6.
- O'Reilly K, Donohoe G, O'Sullivan D, Coyle C, Mullaney R, O'Connell P, Maddock C, Nulty A, O'Flynn P, O'Connell C, Kennedy HG. Study protocol: a randomised controlled trial of cognitive remediation for a national cohort of forensic mental health patients with schizophrenia or schizoaffective disorder. BMC Psychiatry. 2016 Jan 13;16:5. doi: 10.1186/s12888-016-0707-y.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- Central Mental Hospital
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Cognitive Remediation Therapy
-
Hacettepe UniversityRejestracja na zaproszenieAktywność silnika | Dysfunkcja wykonawcza | Orientacja poznawczaIndyk
-
I.R.C.C.S. Fondazione Santa LuciaCampus Bio-Medico UniversityZakończonyUderzenie | Niedowład | Paraliż kończyn górnychWłochy
-
Douglas Mental Health University InstituteRekrutacyjnySchizofrenia | Upośledzenie funkcji poznawczych | PsychozaKanada
-
Karadeniz Technical UniversityZakończonyHemodializa | Samotność | Szczęście | Dostosowanie | Terapia wspomagana przez zwierzęta | ObjawIndyk
-
ARCIM Institute Academic Research in Complementary...University Hospital TuebingenZakończony
-
University of Alabama, TuscaloosaUniversity of Maryland; University of MemphisZakończony
-
Columbia UniversityZakończony
-
NeuroTronik Inc.NieznanyOstra niewydolność sercaPanama
-
NeuroTronik Inc.NieznanyNiewydolność serca | Ostra niewydolność sercaParagwaj
-
University of Applied Sciences and Arts of Southern...Vrije Universiteit Brussel; Universiteit Antwerpen; THIM - die internationale...Zakończony